VENTIVE - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.4
| Stock Code | VENTIVE | Market Cap | 14,492 Cr. | Current Price | 620 ₹ | High / Low | 845 ₹ |
| Stock P/E | 62.9 | Book Value | 202 ₹ | Dividend Yield | 0.00 % | ROCE | 7.07 % |
| ROE | 4.99 % | Face Value | 1.00 ₹ | DMA 50 | 644 ₹ | DMA 200 | 692 ₹ |
| Chg in FII Hold | -0.13 % | Chg in DII Hold | -0.07 % | PAT Qtr | 69.4 Cr. | PAT Prev Qtr | 56.8 Cr. |
| RSI | 42.9 | MACD | 1.39 | Volume | 21,024 | Avg Vol 1Wk | 24,397 |
| Low price | 542 ₹ | High price | 845 ₹ | PEG Ratio | 3.02 | Debt to equity | 0.18 |
| 52w Index | 25.6 % | Qtr Profit Var | 21.4 % | EPS | 9.80 ₹ | Industry PE | 27.0 |
📊 Core Financials:
VENTIVE has shown moderate improvement with quarterly PAT rising from 56.8 Cr. to 69.4 Cr. (↑21.4%). However, ROCE at 7.07% and ROE at 4.99% are weak, reflecting poor efficiency in capital utilization. Debt-to-equity is low at 0.18, indicating manageable leverage. EPS stands at 9.80 ₹, but overall profitability remains modest compared to peers.
💹 Valuation Indicators:
The stock trades at a P/E of 62.9, far above the industry average of 27.0, suggesting significant overvaluation. P/B ratio is ~3.07 (Price 620 ₹ / Book Value 202 ₹), which is moderate. PEG ratio of 3.02 indicates growth is expensive relative to earnings. Intrinsic value appears lower than current levels, limiting margin of safety.
🏢 Business Model & Competitive Advantage:
VENTIVE operates in a competitive sector with diversified offerings. Its competitive advantage lies in scale and established market presence. However, profitability metrics are weaker than industry leaders, limiting its edge. Efficiency in capital utilization and growth sustainability remain concerns.
🎯 Entry Zone & Long-Term Guidance:
Current price (620 ₹) is below both 50 DMA (644 ₹) and 200 DMA (692 ₹), showing bearish momentum. RSI at 42.9 indicates neutral-to-weak strength, while MACD (1.39) shows mild positive momentum. A good entry zone would be 580–600 ₹ if undervaluation emerges. Long-term holding is possible due to sector demand, but stretched valuations and weak profitability warrant caution.
Positive
- 📈 Quarterly PAT growth of 21.4%.
- 💰 Low debt-to-equity (0.18).
- 📊 Reasonable P/B ratio (~3.07).
- 📉 EPS growth supports moderate earnings visibility.
Limitation
- ⚠️ Very high P/E (62.9) vs industry average (27.0).
- 📉 Weak ROCE (7.07%) and ROE (4.99%).
- 📉 PEG ratio high (3.02), growth expensive.
- 📉 Dividend yield is 0.00%, no shareholder returns.
Company Negative News
📰 No major negative news reported recently, but weak profitability metrics and reduced institutional holdings (FII -0.13%, DII -0.07%) raise concerns.
Company Positive News
📰 Quarterly earnings improved with PAT rising to 69.4 Cr. Technical indicators show mild positive momentum despite weak fundamentals.
Industry
🏭 Industry P/E stands at 27.0, much lower than VENTIVE’s valuation. The sector remains competitive, with demand driven by innovation and efficiency, but margins are under pressure.
Conclusion
✅ VENTIVE is financially stable with low debt and moderate earnings growth. However, valuations are stretched, and profitability metrics are weak compared to peers. Best suited for cautious long-term investors who can accumulate near 580–600 ₹. Short-term traders should remain cautious due to weak fundamentals despite mild technical support.
Would you like me to extend this into a sector outlook to see how broader industry trends could impact its valuation and growth trajectory?